CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study
about
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19Pharmacogenetic Associations of β1-Adrenergic Receptor Polymorphisms With Cardiovascular Outcomes in the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review.Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial.Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 GenotypingInvestigating Real-World Clopidogrel Pharmacogenetics in Stroke Using a Bioresource Linked to Electronic Medical Records.Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis.Efficacy and safety of CYP2C19 genotype in stroke or transient ischemic attack patients treated with clopidogrel monotherapy or clopidogrel plus aspirin: Protocol for a systemic review and meta-analysis.
P2860
Q26801867-6BA988CC-6862-4A1B-B28E-8416576382D8Q38378871-E9B39172-73B0-408F-81DF-D7A26E833A22Q38983589-7255CDB4-4348-4FF3-98BC-AD1630A0B24FQ40110995-14CACA07-B642-4A41-BACD-F30786A72690Q42380287-CC56766A-7ACC-468C-AB40-BD628F3F2A4FQ49222788-241E0091-5184-45D7-9C1A-34B487081ADEQ51235778-9D2D09F9-E5DE-4E3F-8C53-5E0477C25B2FQ55402371-FA7B27CB-C39F-4714-9DF9-54C04A15B29E
P2860
CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CYP2C19 metabolizer status and ...... bcortical Strokes (SPS3) study
@ast
CYP2C19 metabolizer status and ...... bcortical Strokes (SPS3) study
@en
type
label
CYP2C19 metabolizer status and ...... bcortical Strokes (SPS3) study
@ast
CYP2C19 metabolizer status and ...... bcortical Strokes (SPS3) study
@en
prefLabel
CYP2C19 metabolizer status and ...... bcortical Strokes (SPS3) study
@ast
CYP2C19 metabolizer status and ...... bcortical Strokes (SPS3) study
@en
P2093
P2860
P356
P1476
CYP2C19 metabolizer status and ...... bcortical Strokes (SPS3) study
@en
P2093
Braxton D Mitchell
Caitrin W McDonough
Joshua P Lewis
Julie A Johnson
Leslie A McClure
Oscar R Benavente
Richard B Horenstein
Robert L Talbert
P2860
P304
P356
10.1161/JAHA.114.001652
P577
2015-05-27T00:00:00Z